Contribution: Infectious Disease Prevention and Control
The University of British Columbia | The University of British Columbia
$1,199,680.00
2021-HQ-000120
FY 2020-21 · 2020-11-01
Summary
P002328
Department
Program
Infectious Disease Prevention and Control
Location
Vancouver | Vancouver, British Columbia, Canada
Recipient Type
Academia
Business Number
108161779
Type
Contribution
Source
Proactive Disclosure - Grants and Contributions
As published
Agreement End Date
2022-03-31
Agreement Number
2021-HQ-000120
Agreement Start Date
2020-11-01
Agreement Title
2021-HQ-000120
Agreement Title (French)
2021-HQ-000120
Agreement Type
Contribution
Agreement Value
$1,199,680.00
Amendment Number
0
Description
P002328
Description (French)
P002328
Expected Results
Not Available
Expected Results (French)
Non Disponible
Organization Code
phac-aspc
Organization
Public Health Agency of Canada | Agence de la santé publique du Canada
Program Name
Infectious Disease Prevention and Control
Program Name (French)
Prévention et contrôle des maladies infectieuses
Program Purpose
To protect Canadians from infectious diseases (e.g., Human Immunodeficiency Virus (HIV), E. Coli and measles) by predicting, detecting, assessing and responding to outbreaks and new threats, and contribute to the prevention, control and reduction of the spread of infectious disease among Canadians.
Program Purpose (French)
Protéger les Canadiens et les Canadiennes contre les maladies infectieuses (p. ex. le virus de l’immunodéficience humaine (VIH), l’E. coli et la rougeole) en prévoyant, en détectant, en évaluant et en traitant les éclosions et les nouvelles menaces, contribuer à la prévention, au contrôle et à la réduction de la propagation des maladies infectieuses chez les Canadiens et les Canadiennes.
Recipient Business Number
108161779
Recipient City
Vancouver | Vancouver
Recipient Country
CA
Recipient Legal Name
The University of British Columbia | The University of British Columbia
Recipient Postal Code
V6T1Z4
Recipient Province or Territory
BC
Recipient Type
S
Reference Number
1480-2020-2021-Qrt4-0000172
